Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss
Public ClinicalTrials.gov record NCT00925600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 3, randomized, double-blind, placebo-controlled study to evaluate new or worsening lens opacifications in men with non-metastatic prostate cancer receiving denosumab for bone loss due to androgen deprivation therapy.
Study identification
- NCT ID
- NCT00925600
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 769 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 30 Years to 120 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009 (Actual)
- Primary completion
- May 12, 2016 (Actual)
- Completion
- May 12, 2016 (Actual)
- Last update posted
- May 30, 2017
2009 – 2016
United States locations
- U.S. sites
- 52
- U.S. states
- 24
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anaheim | California | 92801 | — |
| Research Site | Laguna Hills | California | 92653 | — |
| Research Site | Murrieta | California | 92562 | — |
| Research Site | San Diego | California | 92103 | — |
| Research Site | San Diego | California | 92120 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | San Luis Obispo | California | 93405 | — |
| Research Site | Denver | Colorado | 80204 | — |
| Research Site | Denver | Colorado | 80211 | — |
| Research Site | Englewood | Colorado | 80113 | — |
| Research Site | Middlebury | Connecticut | 06762 | — |
| Research Site | New Britain | Connecticut | 06052 | — |
| Research Site | Trinity | Florida | 34655 | — |
| Research Site | Coeur d'Alene | Idaho | 83814 | — |
| Research Site | Greenwood | Indiana | 46143 | — |
| Research Site | West Des Moines | Iowa | 50266 | — |
| Research Site | Kansas City | Kansas | 66160 | — |
| Research Site | Shreveport | Louisiana | 71106 | — |
| Research Site | Annapolis | Maryland | 21401 | — |
| Research Site | Baltimore | Maryland | 21201 | — |
| Research Site | Greenbelt | Maryland | 20770 | — |
| Research Site | Grand Rapids | Michigan | 49546 | — |
| Research Site | Sartell | Minnesota | 56377 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Missoula | Montana | 59808 | — |
| Research Site | Omaha | Nebraska | 68105-1850 | — |
| Research Site | Omaha | Nebraska | 68130 | — |
| Research Site | Berlin | New Jersey | 08009 | — |
| Research Site | Brick | New Jersey | 08724 | — |
| Research Site | Englewood | New Jersey | 07631 | — |
| Research Site | Lawrenceville | New Jersey | 08648 | — |
| Research Site | Mount Laurel | New Jersey | 08054 | — |
| Research Site | Albany | New York | 12208 | — |
| Research Site | Garden City | New York | 11530 | — |
| Research Site | Kingston | New York | 12401 | — |
| Research Site | New York | New York | 10021 | — |
| Research Site | Poughkeepsie | New York | 12601 | — |
| Research Site | Syracuse | New York | 13210 | — |
| Research Site | Gastonia | North Carolina | 28054 | — |
| Research Site | Greenville | North Carolina | 27834 | — |
| Research Site | Cincinnati | Ohio | 45212 | — |
| Research Site | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Research Site | Lancaster | Pennsylvania | 17604 | — |
| Research Site | Philadelphia | Pennsylvania | 19107 | — |
| Research Site | Myrtle Beach | South Carolina | 29572 | — |
| Research Site | Knoxville | Tennessee | 37920 | — |
| Research Site | Austin | Texas | 78759 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Temple | Texas | 76508 | — |
| Research Site | Richmond | Virginia | 23235 | — |
| Research Site | Salem | Virginia | 24153 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 120 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00925600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 30, 2017 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00925600 live on ClinicalTrials.gov.